RS Crum Inc’s iShares Biotechnology ETF IBB Stock Holding History

RS Crum Inc’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.93M	Buy	9,186 +75	+0.8%	+$15K	0.36%	28
2026 Q2	$1.73M	Sell	9,111 -340	-4%	-$58.4K	0.32%	30
2026 Q1	$1.6M	Hold	9,451	–	–	0.31%	33
2025 Q4	$1.6M	Hold	9,451	–	–	0.32%	30
2025 Q3	$1.36M	Hold	9,451	–	–	0.3%	32
2025 Q2	$1.2M	Hold	9,451	–	–	0.29%	32
2025 Q1	$1.21M	Sell	9,451 -205	-2%	-$27.8K	0.33%	31
2024 Q4	$1.28M	Hold	9,656	–	–	0.32%	32
2024 Q3	$1.41M	Sell	9,656 -127	-1%	-$18.4K	0.33%	31
2024 Q2	$1.34M	Hold	9,783	–	–	0.35%	31
2024 Q1	$1.34M	Sell	9,783 -145	-1%	-$19.8K	0.37%	30
2023 Q4	$1.35M	Sell	9,928 -160	-2%	-$19.5K	0.42%	30
2023 Q3	$1.23M	Hold	10,088	–	–	0.44%	32
2023 Q2	$1.28M	Sell	10,088 -21	-0.2%	-$2.73K	0.46%	33
2023 Q1	$1.31M	Hold	10,109	–	–	0.5%	31
2022 Q4	$1.33M	Sell	10,109 -2,965	-23%	-$383K	0.62%	30
2022 Q3	$1.53M	Hold	13,074	–	–	0.8%	21
2022 Q2	$1.54M	Hold	13,074	–	–	0.79%	22
2022 Q1	$1.7M	Sell	13,074 -288	-2%	-$37.5K	0.96%	20
2021 Q4	$2.04M	Buy	+13,362	New	+$2.07M	1.13%	18

Other funds holding IBB

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $375B AUM 21.05% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.9B AUM 22.61% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $64.4B AUM 36.06% 1-Year Est. Return

RS Crum Inc's IBB Position: Q3 2026 in Review

RS Crum Inc increased its iShares Biotechnology ETF (IBB) stake by 0.82% in Q3 2026, buying an estimated $15K and bringing the position to 9,186 shares worth $1.93M. The position accounts for 0.36% of the portfolio, ranked #28.

RS Crum Inc first reported a position in IBB in Q4 2021 and has held it in 20 quarters since. The position peaked at $2.04M in Q4 2021. 907 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

RS Crum Inc held 9,186 shares of iShares Biotechnology ETF worth $1.93M as of Q3 2026.
RS Crum Inc bought 75 iShares Biotechnology ETF shares in Q3 2026, an estimated $15K.
iShares Biotechnology ETF made up 0.36% of RS Crum Inc's portfolio in Q3 2026, its #28 holding.
RS Crum Inc first reported a position in iShares Biotechnology ETF in Q4 2021 and has held it in 20 quarters since.
RS Crum Inc's iShares Biotechnology ETF position peaked at $2.04M in Q4 2021.
907 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on RS Crum Inc's 13F filing for Q3 2026, filed 19 Oct 2026.